Proceedings of the first global workshop on breast cancer: Pathways to the evaluation and clinical development of novel agents for breast cancer

Keyphrases

• Breast Cancer 100%
• Disease Outcome 100%
• Clinical Development 100%
• Novel Agents 100%
• Cancer Pathways 100%
• Clinical Setting 66%
• Angiogenesis 33%
• In Cancer 33%
• Signaling Pathway 33%
• Therapeutic Potential 33%
• Tumor Progression 33%
• Clinical Trial Design 33%
• Patient's Will 33%
• Dysregulated 33%
• Tumor Biology 33%
• Treatment Options 33%
• Metastatic Disease 33%
• Cellular Processes 33%
• Breast Tumor 33%
• Accruals 33%
• Adjuvant Therapy 33%
• Breast Cancer Research 33%
• DNA Repair 33%
• Adjuvant Chemotherapy 33%
• Neoadjuvant Setting 33%
• Early Breast Cancer 33%
• Local Therapy 33%
• Patient Selection 33%
• Tumor Development 33%
• Current Management 33%
• Number of Treatment 33%
• Gene Testing 33%
• Patients with Breast Cancer 33%
• Overcoming Resistance 33%
• HER2 Signaling 33%
• Selection Management 33%
• Expert Views 33%
• Toxicity Management 33%

Medicine and Dentistry

• Breast Cancer 100%
• Diseases 42%
• Patient Selection 14%
• Neoplasm 14%
• Adjuvant Therapy 14%
• Adjuvant Chemotherapy 14%
• Angiogenesis 14%
• Metastatic Carcinoma 14%
• Clinical Trial Design 14%
• Cancer Research 14%
• Malignant Neoplasm 14%
• Tumor Biology 14%
• DNA Repair 14%
• Local Therapy 14%
• Cell Signaling Pathway 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Diseases 42%
• Neoplasm 28%
• Chemotherapy 14%
• Clinical Trial Design 14%
• Cellular Processes 14%
• Malignant Neoplasm 14%